Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Cue Biopharma Inc’s current trading price is -79.14% away from its 52-week high, while its distance from the 52-week low is -17.74%. The stock’s price range during this period has varied between $1.24 and $4.89. The company, active in the Healthcare sector, saw a trading volume of around 1.53 million for the day, considerably higher average daily volume of 0.35 million observed over the last three months.
Cue Biopharma Inc’s stock has seen a rocky market performance. The company’s stock achieved a 1-year high of $4.89 on 07/17/23, and the lowest price during that time was $1.24, recorded on 07/01/24.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
How Financial Performance Impacts Market Capitalization
Cue Biopharma Inc (CUE) has experienced a quarterly decline of -46.32% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 49.61M and boasts a workforce of 53 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.7932, with a change in price of -1.4900. Similarly, Cue Biopharma Inc recorded 331,193 in trading volume during the last 100 days, posting a change of -59.36%.
How CUE’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for CUE stands at 0.43. Similarly, the long-term debt-to-equity ratio is also 0.19.
CUE Stock Stochastic Average
As of today, the raw stochastic average of Cue Biopharma Inc over the last 50 days is at 6.27%. This shows a declinee from the raw stochastic average of the previous 20 days, which was recorded at 9.72%. Further, the company’s Stochastic %K and %D values for the last 20 days were 19.59% and 25.19%, respectively.
CUE Stock Price Performance Analysis
Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. Until today this year the stock’s price performance recorded a decrease of -61.36%. However, over the last six months, the performance has been stronger by -64.08%. The price of CUE decreased -35.85% over the last 30 days. And in the last five days, it has fallen by -30.61%.
